Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals

被引:198
作者
Sedighi, Mansour [1 ]
Razavi, Shabnam [1 ,2 ]
Navab-Moghadam, Fatemeh [1 ]
Khamseh, Mohammad E. [3 ]
Alaei-Shahmiri, Fariba [4 ]
Mehrtash, Amirhosein [5 ]
Amirmozafari, Nour [1 ,2 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran 1439914153, Iran
[2] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran
[5] Pasteur Inst Iran, Biotechnol Res Ctr, Mol Med Dept, Tehran, Iran
关键词
Gut microbiota; Bacterial compositions; Type 2 diabetes mellitus; Metabolic syndrome; Real-time PCR; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; BACTERIA; ASSOCIATION; RELIABILITY; METABOLISM; IMPACTS; ENERGY;
D O I
10.1016/j.micpath.2017.08.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies indicate that inflammatory reactions leading to the development of type 2 diabetes mellitus (T2DM) may also contribute to variations in the composition of the intestinal microbiota, suggesting a relation between T2DM and bacterial residents in the intestinal tract. This case-control study was designed to evaluate the composition of the gut microbiota dominant bacterial groups in patients with T2DM compared to the healthy people. A total of 36 adult subjects (18 patients diagnosed with T2DM and 18 healthy persons) were included in the study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method using bacterial 16S rRNA gene. The quantities of two groups of bacteria were meaningfully different among T2DM patients and healthy individuals. While, the level of Lactobacillus was significantly higher in the patients with T2DM (P value < 0.001), Bifidobacterium was significantly more frequent in the healthy people (P value < 0.001). The quantities of Prevotella (P value = 0.0.08) and Fusobacterium (P value = 0.99) genera in faecal samples were not significantly different between the two groups. The significant alterations in dominant faecal bacterial genera found in T2DM patients participating in the current study highlight the link between T2DM disease and compositional variation in intestinal flora. These findings may be valuable for developing approaches to control T2DM by modifying the gut microbiota. More investigations with focus on various taxonomic levels (family, genus and species) of bacteria are necessary to clarify the exact relevance of changes in the gut microbial communities with the progression of T2DM disorder. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [41] Patients with Acne Vulgaris Have a Distinct Gut Microbiota in Comparison with Healthy Controls
    Deng, Yongqiong
    Wang, Hong
    Zhou, Jiyuan
    Mou, Yunzhu
    Wang, Guiqiang
    Xiong, Xia
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (08) : 783 - 790
  • [42] Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
    Shang, Junjie
    Liu, Fang
    Zhang, Bing
    Dong, Kunlun
    Lu, Man
    Jiang, Rongfeng
    Xu, Yue
    Diao, Le
    Zhao, Jiangman
    Tang, Hui
    PEERJ, 2021, 9
  • [43] Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
    Candela, Marco
    Biagi, Elena
    Soverini, Matteo
    Consolandi, Clarissa
    Quercia, Sara
    Severgnini, Marco
    Peano, Clelia
    Turroni, Silvia
    Rampelli, Simone
    Pozzilli, Paolo
    Pianesi, Mario
    Fallucca, Francesco
    Brigidi, Patrizia
    BRITISH JOURNAL OF NUTRITION, 2016, 116 (01) : 80 - 93
  • [44] Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
    Tao, Sibei
    Li, Lingzhi
    Li, Ling
    Liu, Yuan
    Ren, Qian
    Shi, Min
    Liu, Jing
    Jiang, Jing
    Ma, Huichao
    Huang, Zhuo
    Xia, Zijing
    Pan, Jing
    Wei, Tiantian
    Wang, Yan
    Li, Peiyun
    Lan, Tian
    Tang, Xi
    Zeng, Xiaoxi
    Lei, Song
    Tang, Huairong
    Ma, Liang
    Fu, Ping
    ACTA DIABETOLOGICA, 2019, 56 (05) : 581 - 592
  • [45] Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
    Wu, Jiaqiang
    Yang, Kangping
    Fan, Hancheng
    Wei, Meilin
    Xiong, Qin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [46] Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus
    Salgaco, Mateus Kawata
    Segura Oliveira, Liliane Garcia
    Costa, Giselle Nobre
    Bianchi, Fernanda
    Sivieri, Katia
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (23-24) : 9229 - 9238
  • [47] Gut resistomes, microbiota and antibiotic residues in Chinese patients undergoing antibiotic administration and healthy individuals
    Duan, Yujing
    Chen, Zeyou
    Tan, Lu
    Wang, Xiaolong
    Xue, Yingang
    Wang, Shaopeng
    Wang, Qing
    Das, Ranjit
    Lin, Huai
    Hou, Jie
    Li, Linyun
    Mao, Daqing
    Luo, Yi
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 705
  • [48] Role of gut microbiota in type 2 diabetes pathophysiology
    Gurung, Manoj
    Li, Zhipeng
    You, Hannah
    Rodrigues, Richard
    Jump, Donald B.
    Morgun, Andrey
    Shulzhenko, Natalia
    EBIOMEDICINE, 2020, 51
  • [49] The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
    Aydin, Omrum
    Nieuwdorp, Max
    Gerdes, Victor
    CURRENT DIABETES REPORTS, 2018, 18 (08)
  • [50] Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products
    Xia, Fan
    Wen, Lu-Ping
    Ge, Bing-Chen
    Li, Yu-Xin
    Li, Fang-Ping
    Zhou, Ben-Jie
    WORLD JOURNAL OF DIABETES, 2021, 12 (08) : 1146 - 1163